BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, June 21, 2026
Home » Authors » Omar Ford

Articles by Omar Ford

CT scans shown to reduce likelihood of hospitalizations

Aug. 12, 2011
By Omar Ford
CT scans are powerful and can provide a lot of information quickly that can be especially useful in the emergency department where patients are often very sick and time is critical. CT scans allow doctors to arrive at a diagnosis quickly.
Read More

Med-tech faces uncertainty in healthcare landscape

Aug. 11, 2011
By Omar Ford
ATLANTA — If there was one word that could properly describe the feelings of medical device makers across the U.S., that word would be uncertainty. (Medical Device Daily)
Read More

MindFrame ischemic stroke device successful in human procedure

Aug. 10, 2011
By Omar Ford
MindFrame (Irvine, California) could be one step closer in its bid to secure FDA approval for its ischemic stroke treatment device. The med-tech firm reported the successful first-in-human procedure related to its MindFrame Capture LP at Katherinen Hospital (Stuttgart, Germany). (Medical Device Daily)
Read More

Kelyniam switches to med-tech industry, with skull implants

Aug. 9, 2011
By Omar Ford
For years, James Ketner manufactured parts for aircraft. That was until about a couple of years ago when Ketner's company, Kelyniam (New Britain, Connecticut), began supplying Stereolithography models to a device manufacturer. The experience served as a catalyst for Ketner and the company to shift focus to the med-tech industry. (Medical Device Daily)
Read More

Covidien's stents evaluated in two Iliac clinical studies

Aug. 8, 2011
By Omar Ford

Neuronetics seeks to corner market on treating depression

Aug. 4, 2011
By Omar Ford
When it comes to the use of medical devices treating psychiatric disorders, the future is now according to Neuronetics, (Malvern, Pennsylvania), a small med-tech startup that has seen tremendous growth in the past few years. The belief that pharmaceuticals are the only reliable treatment option for mental illness is quickly becoming outdated. (Medical Device Daily)
Read More

EAST investigating if early AF intervention stops adverse events

Aug. 3, 2011
By Omar Ford

Deals roundup: FMC to acquire Liberty Dialysis, AACH for nearly $2 billion

Aug. 3, 2011
By Omar Ford

Medtronic gains FDA approval for Advisa pivotal clinical trial

Aug. 2, 2011
By Omar Ford
As the population ages, the use of pacemakers is growing, with roughly five million patients worldwide who currently are implanted with a pacemaker or implantable cardioverter-defibrillator. At the same time, the use of MRI as a diagnostic tool is increasing, with nearly 30 million scans completed in 2007. People over age 65 are twice as likely to need an MRI compared to younger patients and between 50% and 75% of patients with electronic heart devices will likely need an MRI at some point. This could lead to complications in these patients. (Medical Device Daily)
Read More

Covidien's PUFS clinical trial data is favorable for device

Aug. 1, 2011
By Omar Ford
Previous 1 2 … 148 149 150 151 152 153 154 155 156 … 227 228 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 18, 2026.
  • Wireframe of feet and scale

    GLP-1s need technologies for long-term use

    BioWorld
    For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
  • UTRN gene involved in arthrogryposis, study finds

    BioWorld Science
    Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
  • Blue-gray dollar sign

    HMNC raises $50M series B to prep depression drugs for phase III

    BioWorld
    HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...
  • Illustration of glucose in the blood stream

    CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research

    BioWorld Science
    Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing